Importance of apoptotic mechanisms in inflammatory infiltrate of oral lichen planus lesions

Anticancer Research

Volumn 26, Issue 1 A, 2006, Pages 357-362

  Bascones Ilundain, Cristina ^a   Gonzalez Moles, Miguel Angel ^b   Esparza Gómez, Germán ^a   Gil Montoya, José Antonio ^b   Bascones Martínez, Antonio ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Apoptosis; Caspase 3; Inflammatory infiltrate; Oral lichen planus; p21; TUNEL

Indexed keywords

CASPASE 3; PROTEIN P21;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ANALYSIS; EPITHELIUM CELL; HUMAN; INFLAMMATORY INFILTRATE; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MOUTH LESION; NICK END LABELING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

APOPTOSIS; CASPASE 3; CASPASES; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INFLAMMATION; LICHEN PLANUS;

EID: 32144435791     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lo Muzio L, Mignogna MD, Favia G, Procaccini M, Testa NF and Bucci E: The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 34: 239-246, 1998.
2. Duffey D, Eversole LR and Abemayor E: Oral lichen planus and its association with squamous cell carcinoma: an update on pathogenesis and treatment implications. Laryngoscope 106: 357-362, 1996.
3. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? The Lancet 357: 539-545, 2001.
4. Weitzman SA and Gordon LI: Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76: 655-663, 1990.
5. O'Byrne KJ and Dalgleish AG: Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85: 473-483, 2001.
6. Mignona MD, Fedele S, Lo Russo L, Lo Muzio L and Bucci E: Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncology 40: 120-130, 2004.
7. Bascones C, Gonzalez-Moles MA, Esparza G, Bravo M, Acevedo A, Gil-Montoya JA and Bascones A: Apoptosis and cell cycle arrest in oral lichen planus. Hypothesis on their possible influence on its malignant transformation. Archives Oral Biol, in press, 2005.
8. Neppelberg E, Johannessen AC and Jonsson R: Apoptosis in oral lichen planus. Eur J Oral Sci 109: 361-364, 2001.
9. Sklavounou A, Chrysomali E, Scorilas A and Karameris A: TNF-α expression and apoptosis regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation. J Oral Pathol Med 29: 370-375, 2000.
10. Sugerman PB, Savage NW, Walsh SL et al: The pathogenesis of the oral lichen planus. Crit Oral Biol Med 13: 350-365, 2002.
11. Van der Meij E, Schepman K and Van der Waal I: The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 164-171, 2003.
12. Bloor BK, Malik FK, Odell EW and Morgan PR: Quantitative assessment of apoptosis in oral lichen planus. Oral Surg Oral Med Oral Pathol Radiol Endod 88: 187-195, 1999.
13. Olumi AF, Grossfeld GD, Hayward AW, Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011, 1999.
14. Liotta LA and Kohn EC: The microenvironment of the humour-host interface. Nature 411: 375-379, 2001.
15. Dekker NP, Lozada-Nür F, Lagenaur LA, Macphail LA, Bloom CY and Regezi JA: Apoptosis-associated markers in oral lichen planus. J Oral Pathol Med 26: 170-175, 1997.
16. Hudson JD, Shaoib MA, Maestro R, Carnero A, Hannon GJ and Beach DHA: Proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190: 1375-1382, 1999.
17. Kirschner LS: Signaling pathway in adrenocortical cancer. Ann NY Acad Sci 968: 222-239, 2002.
18. Kane LP, Mollenauer MN, Xu Z, Turck CW and Weiss A: Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Mol Cell Biol 22: 5962-5974, 2002.
19. Taketo MM: Cyclooxigenase-2 inhibitors in tumorogenesis (Part II). J Natl Cancer Inst 90: 1609-1620, 1998.
20. Uotila P: The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother 43: 1-9, 1996.
21. Vane JR, Bakhle YS and Botting RM: Cyclooxigenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998.
22. Tsuji S, Kawano S, Sawaoka H, Takei Y, Kobayashi I, Nagano K, Fusamoto H and Kamada T: Evidences for involvement of cyclooxigenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot Essent Fatty Acids 55: 179-183, 1996.
23. McGinty A, Chang YW, Sorokin A, Bokemeyer D and Dunn MJ: Cyclooxigenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor differentiated PC12 cells. J Biol Chem 275: 12095-12101, 2000.
24. Subbaramaiah K, Zakim D, Weksler BB and Dannenberg AJ: Inhibition of cyclooxigenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med 216: 201-210, 1997.
25. Taniguchi Y, Nagao T, Maeda H, Kameyama Y and Warnakulasuriya KAAS: Epithelial cell proliferation in oral lichen planus. Cell Prolif 35: 103-109, 2002.
26. Maidhof R, Hornstein G, Bauer A, Schönberger A and Bäurle G: Cell proliferation in lichen planus of the buccal mucosa. Acta Dematovener 61: 17-22, 1981.
27. da Silva Fonseca LM and do Carmo MAV: Identification of the AgNORs, PCNA and ckl16 proteins in oral lichen planus lesions. Oral Diseases 7: 344-348, 2001.